Dr Lin obtained his PhD degree in Cancer Biology at the University of Hong Kong in 2017 He has a strong track record in cancer research with extensive experience in establishing and characterising of patient-derived xenografts and cell lines. His research provided extremely fundamental models for the research communities of nasopharyngeal carcinoma and Epstein- Barr virus, leading to multiple publications during his PhD training, including a first-author publication in Nature Communications.

In 2018, he moved to Perth and has been a postdoctoral research fellow as part of Western Australian Cancer Single Cell Consortium. He currently leads the project on the analysis of metastatic uveal melanoma across multiple laboratories and hospital departments. He applies state-of-the-art technology such as single-cell RNA sequencing and spatial transcriptomics to study cell-cell interactions in the tumour microenvironment. His expertise in cancer research and advanced methodologies enables him to identify novel therapeutic targets for cancer patients.

Since 2019, Dr Lin has been awarded over $170,000 in research funding as chief investigator including a Cancer Council Western Australia Collaborative Grant as CIA to carry out a study on metastatic uveal melanoma. He was awarded a Spatial Pioneers Fellowship and a Visium Spatial Biology Kickstarter Award by 10x Genomics in 2021.

Dr Lin is a member of the Telethon Kids Institute Animal Ethics Committee (2021 - current). He was a member of multiple committees including the Pre-doctoral Grants Advisory Subcommittee at Cancer Council WA (2021 - 2022) and the early-career research symposium organising committee of Human Genome Meeting in 2020. He served as a guest editor for Frontiers in Cellular and Infection Microbiology, and as a reviewer for journals such as Cancers, Frontiers in Microbiology and Scientific Reports.

Dr Lin has supervised 3 PhD students (2 completed).

English, Mandarin, Cantonese, Teochew